glp-1 receptor agonists effects on cardiovascular risk reduction of cardiometabolic outcomes in heart transplant recipients: A systematic review and meta-analysis of observational studies GLP-1 receptor agonists confer 'modest'
Description
doi: 10.1056/NEJMoa1916038 [DOI] [PubMed] [Google Scholar] 98
Sassoon, D
Compared to placebo, SGLT2is/metformin (WMD: 7.74
Once-weekly semaglutide in adults with overweight or obesity
& Mansell, P
H.DicksonS
